Study Evaluating Techniques for Measuring Tear Production
Status:
Completed
Trial end date:
2021-12-10
Target enrollment:
Participant gender:
Summary
This will be a vehicle-controlled, masked, randomized study conducted at a single site in the
United States. All participants enrolled will have Dry Eye Disease (DED). The study will
consist of 2 Visits. At Visit 1, eligibility will be assessed at Screening. All eligible
subjects will then be enrolled and randomized to one of two treatment groups (1:1): active
(0.003% AR-15512) or control (AR-15512 vehicle). Subjects in each treatment group will then
be randomized 1:1 to which Visit (Visit 1 or 2) anesthetic will be used with the Schirmer
test.